De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus
- Ryan, Conor S. MD
- Fine, Anthony L. MD
- Cohen, Alexander L. MD, PhD
- Schiltz, Brenda M. MD
- Renaud, Deborah L. MD
- Wirrell, Elaine C. MD
- Patterson, Marc C. MD
- Boczek, Nicole J. PhD
- Liu, Raymond PhD
- Babovic-Vuksanovic, Dusica MD
- Chan, David C. MD, PhD
- Payne, Eric T. MD
Background:
The dynamin 1-like gene (DNM1L) encodes a GTPase that mediates mitochondrial and peroxisomal fission and fusion. We report a new clinical presentation associated with a DNM1L pathogenic variant and review the literature.
Results:
A 13-year-old boy with mild developmental delays and paroxysmal dystonia presented acutely with multifocal myoclonic super-refractory status epilepticus. Despite sustained and aggressive treatment, seizures persisted and care was ultimately withdrawn in the context of extensive global cortical atrophy. Rapid trio-whole exome sequencing revealed a de novo heterozygous c.1207C>T (p.R403C) pathogenic variant in DNM1L. Immunofluorescence staining of fibroblast mitochondria revealed abnormally elongated and tubular morphology.
Conclusions:
This case highlights the diagnostic importance of rapid whole exome sequencing within a critical care setting and reveals the expanding phenotypic spectrum associated with DNM1L variants. This now includes progressive paroxysmal dystonia and adolescent-onset super-refractory myoclonic status epilepticus contributing to strikingly rapid and progressive cortical atrophy and death.